Zurueck zur Suche

Reporte zur Charge UT8072AA

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

8Reporte angezeigt
0Todesfaelle
1Hospitalisiert
1Lebensbedrohlich
0Bleibende Schaeden
CT 2 WI 2 KY 1 MD 1 IL 1 AK 1

VAERS 2709341

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UT8072AA

schwer
Staat
KY
Alter
73,0
Geschlecht
F
Eingang
03.11.2023
Impfdatum
18.10.2023
Beginn
22.10.2023
Tage bis Beginn
4,0
Dosis
N/A
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Atrial fibrillation Cardioversion Hypotension Shock

Symptomtext

New onset atrial fibrillation with rapid ventricular response associated with hypotension and shock

Weitere VAERSDATA-Felder
Praegender Schweregrund
Shock
Hospital-Tage
5,0
Labordaten
Hospitalized; cardioverted; placed on Eliquis, flecainide and Diltiazem
Aktuelle Erkrankungen
Osteopenia Gallstones GERD Mild intermittent asthma
Vorgeschichte
Osteopenia Gallstones GERD Mild intermittent asthma
Andere Medikamente
1) alendronate 70 mg oral tablet, 1 PO Q week empty stomach water only stay upright 30 minutes 2) Premarin 0.625 mg oral tablet, Q day 3) Synthroid 100 mcg (0.1 mg) oral tablet, 1 PO Q day on empty stomach 4) Ventolin HFA 90 mcg/inh inhalat
Allergien
Celebrex, gabapentin, Lyrica, Cymbalta
Vorherige Impfungen
-

VAERS 2713156

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UT8072AA

mild
Staat
MD
Alter
85,0
Geschlecht
F
Eingang
13.11.2023
Impfdatum
26.10.2023
Beginn
26.10.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Blindness unilateral Dizziness Fatigue Gait disturbance

Symptomtext

Patient says that she lost vision in her left eye about 45 minutes to an hour after receiving her vaccinations. She was aslo extremely fatigued and went to lay down. She woke up the next morning, told a friend about the incident but did not seek any medical intervention. She also told her friend she felt a little dizzy, was swaying , and staggering when she woke up but that resolved itself as the day progressed. Her vision loss had also resolved itself the next morning.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dizziness
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
Fluzone quadrivalent high dose
Vorgeschichte
Patient has a pace maker
Andere Medikamente
unknown
Allergien
unknown
Vorherige Impfungen
-

VAERS 2708799

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UT8072AA

mild
Staat
CT
Alter
67,0
Geschlecht
M
Eingang
02.11.2023
Impfdatum
18.10.2023
Beginn
20.10.2023
Tage bis Beginn
2,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Anion gap Blood chloride increased Blood creatinine increased Blood glucose normal Blood potassium normal Blood sodium normal Blood urea decreased C-reactive protein Carbon dioxide normal Creatinine urine Full blood count normal Glomerular filtration rate decreased Glycosylated haemoglobin normal Haematocrit normal Haemoglobin normal Inflammation Oral mucosal eruption Platelet count normal

Symptomtext

He developed a full body rash, red like bumps and blotchy. Very itchy. Bumps were in his mouth and everywhere. He was put on Steroids and Benadryl Rash is still resolving. He hasn't needed Benadryl in 2 days and is almost done with the steroids No respiratory issues

Weitere VAERSDATA-Felder
Praegender Schweregrund
Rash
Hospital-Tage
-
Labordaten
CRP inflammation 4.5, Na 144, K+ 4.1, CHL 107, CO2 27, BUN 9, Creatinine 1.30, Egfr 60, Glucose 91, anion gap 10, ESR 32, WBC 6.9. RBC 4.9, Hgb 14.7, HCT 43.9, plt 199, all other CBC results normal, A1c 5.0, Urinalysis neg, Urine Protein 14.1, Creatinine spot urine 273.9, Prot/Creat ratio spot urine 51
Aktuelle Erkrankungen
none
Vorgeschichte
Chronic Hep C, HTN, Steatosis of Liver, OSA, Gout, Low Back Pain, toenail fungus, acute sinusitis
Andere Medikamente
Acetaminophin 500mg 2 every 8 hrs, Diclofenac top gel, Amlodipine 10mg daily, Atorvastatin 20mg daily, lidocaine oint, Lisinopril 20mg daily, Sildenafil 100mg PRN, Allopurinol 100mg BID
Allergien
no known allergies
Vorherige Impfungen
-

VAERS 2683024

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UT8072AA

mild
Staat
IL
Alter
84,0
Geschlecht
F
Eingang
18.09.2023
Impfdatum
14.09.2023
Beginn
14.09.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Urticaria

Symptomtext

diffuse urticaria. no angioedema. no involvement mucosal surfaces. starting few hours after administration of vaccine. seen by urgent care 2 days later adn started on zyrtec and prednisone. urticaria symptoms persist on day 4 despite treatment

Weitere VAERSDATA-Felder
Praegender Schweregrund
Urticaria
Hospital-Tage
-
Labordaten
9/14/2023 urgent care visit. no labs done
Aktuelle Erkrankungen
None
Vorgeschichte
HTN, HLD, GERD
Andere Medikamente
aspirin, coreg, atorvastatin, protonix, digestive enzymes, aspirin, fish oil, vitamin D
Allergien
codeine, hydrocodone, morphine - (mental status changes). levaquin (neck stiffness)
Vorherige Impfungen
-

VAERS 2702618

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge ut8072aa

gering
Staat
CT
Alter
69,0
Geschlecht
F
Eingang
26.10.2023
Impfdatum
26.10.2023
Beginn
26.10.2023
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Extra dose administered

Symptomtext

inadvertent double administration of fluzone vaccine. first received 10/4/2023. second 10/26/2023.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
n/a
Aktuelle Erkrankungen
n/a
Vorgeschichte
hyperlipidemia, gerd, hypothyroid, urinary incontinence, sleep apnea, schizoaffective d/o
Andere Medikamente
olanzapine, risperidone, prazosin, benztropine mesylate, melatonin, escitalopram, pantoprazole, levothyroxine, oxybutynin, pravastatin, losartan, clonazepam, multiple vitamins
Allergien
lisinopril
Vorherige Impfungen
-

VAERS 2698867

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UT8072AA

gering
Staat
AK
Alter
77,0
Geschlecht
M
Eingang
19.10.2023
Impfdatum
10.10.2023
Beginn
10.10.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Poor quality product administered Product storage error

Symptomtext

Fluzone High-dose and was administered to a patient post-excursion with no reported adverse event; Initial information received on 11-Oct-2023 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 77 years old male patient and reporter reported that the Influenza Quadrival A-B High Dose Hv Vaccine [Fluzone High-Dose Quadrivalent] was administered to a patient post-excursion with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 10-Oct-2023, the patient received a unknown dose of suspect Influenza Quadrival A-B High Dose Hv Vaccine (strength, expiry date, formulation: not reported and Frequency: once; lot UT8072AA) via intramuscular route in unknown administration site as immunization and was administered after post-excursion with no reported adverse event (poor quality product administered) (same day latency). Reportedly: Fluzone High-dose Quadrivalent was exposed to Low temperature reached: - 6.4?C. Duration out of labelled range: 3 hours and 50 minutes Human error was unknown, the extended stability data was not cover the excursion, Administered to a patient: YES, Previous excursion: None Action taken: not applicable. At time of reporting, the outcome was Unknown for the event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive and Regulatory Authority Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2688261

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UT8072AA

gering
Staat
WI
Alter
-
Geschlecht
U
Eingang
28.09.2023
Impfdatum
21.09.2023
Beginn
21.09.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Accidental exposure to product Device leakage No adverse event

Symptomtext

the liquid starts leaking where the needle is attached and onto the patient's shoulder as they try to push down the plunger with no reported adverse event; Initial information received on 21-Sep-2023 regarding an unsolicited valid non-serious case received from a pharmacist. This case involves an unknown age and unknown gender patient for whom reporter reported, the liquid starts leaking where the needle is attached and onto the patient's shoulder as they try to push down the plunger with no reported adverse event while receiving influenza quadrival A-B high dose HV vaccine [Fluzone High-Dose Quadrivalent]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 21-Sep-2023, the patient received a dose of suspect influenza quadrival A-B high dose HV vaccine (lot UT8072AA, expiry date- 30-JUN-2024) (with an unknown strength, formulation, dosage) via unknown route in unknown administration site for Immunization. On 21-SEP-2023 the reporter reported that the liquid starts leaking where the needle is attached and onto the patient's shoulder as they try to push down the plunger with no reported adverse event (accidental exposure to product) (latency- same day) following the administration of influenza quadrival A-B high dose HV vaccine. Reportedly, Pharmacist is reporting a recurring issue with FLUZONE HD QIV administration. They report that after the needle is attached to the pen tip, it doesn't seem to have a good seal and the liquid starts leaking where the needle is attached and onto the patient's shoulder as they try to push down the plunger. Action taken was not applicable. At time of reporting, the outcome was Unknown for the event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Accidental exposure to product
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2687028

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UT8072AA

gering
Staat
WI
Alter
78,0
Geschlecht
M
Eingang
27.09.2023
Impfdatum
18.09.2023
Beginn
18.09.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Device connection issue Incorrect dose administered Syringe issue

Symptomtext

When attempting to administer high dose flu vaccine, medication would expel from joint where syringe and needle meet and not directly through the syringe. This is despite the needle clicking into place. These are prefilled syringes. Because the vaccine is actually dispensing out of the side/joint, there is concern about insufficient quantity or an unknown amount of the vaccine actually being administered to patients.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Device connection issue
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-